Review paper
Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials
Abstract
Programmed cell death (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitors have been increasingly used in cancer therapy. Understanding the treatment-related adverse events of these drugs is critical for clinical practice.To evaluate the incidences of treatment-related adverse events of PD-1 and PD-L1 inhibitors and the differences between different drugs and cancer types.PubMed, Web of Science, Embase, and Scopus were searched from...
Paper Details
Title
Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials
Published Date
Jul 1, 2019
Journal
Volume
5
Issue
7
Pages
1008 - 1008
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History